Coherus BioSciences, Inc. (CHRS)
NASDAQ: CHRS · Real-Time Price · USD
1.100
+0.279 (33.90%)
At close: Nov 20, 2024, 4:00 PM
0.971
-0.129 (-11.75%)
Pre-market: Nov 21, 2024, 5:49 AM EST
Coherus BioSciences Market Cap
Coherus BioSciences has a market cap or net worth of $126.73 million as of November 21, 2024. Its market cap has decreased by -53.93% in one year.
Market Cap
126.73M
Enterprise Value
298.92M
1-Year Change
-53.93%
Ranking
Category
Stock Price
$1.10
Market Cap Chart
Since November 6, 2014, Coherus BioSciences's market cap has decreased from $404.20M to $126.73M, a decrease of -68.65%. That is a compound annual growth rate of -10.90%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Nov 20, 2024 | 126.70M | -65.83% |
Dec 29, 2023 | 370.80M | -39.81% |
Dec 30, 2022 | 616.00M | -49.73% |
Dec 31, 2021 | 1.23B | -2.13% |
Dec 31, 2020 | 1.25B | -0.83% |
Dec 31, 2019 | 1.26B | 105.12% |
Dec 31, 2018 | 615.60M | 20.73% |
Dec 29, 2017 | 509.90M | -58.50% |
Dec 30, 2016 | 1.23B | 37.60% |
Dec 31, 2015 | 893.00M | 64.52% |
Dec 31, 2014 | 542.80M | 34.29% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Zomedica | 128.57M |
Adverum Biotechnologies | 128.35M |
Compugen | 128.04M |
Zentek | 127.35M |
Fennec Pharmaceuticals | 127.29M |
Outlook Therapeutics | 124.90M |
Telomir Pharmaceuticals | 124.36M |
Protalix BioTherapeutics | 124.29M |